Nurix Therapeutics, Inc.（NRIX）内部人交易：高管与董事近期交易
过去 18 个月，共有 4 位内部人为 Nurix Therapeutics, Inc.（NRIX）报告了 127 笔 Form 4 交易（最近一笔 2026-10-02）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Ring Christine | Chief Legal Officer | 买入 | 5,786 | $50,454 |
| 2026-10-02 | Ring Christine | Chief Legal Officer | 卖出 | 5,786 | $134,149 |
| 2026-09-02 | Ring Christine | Chief Legal Officer | 买入 | 5,787 | $50,463 |
| 2026-09-02 | Ring Christine | Chief Legal Officer | 卖出 | 5,387 | $138,417 |
| 2026-09-02 | Ring Christine | Chief Legal Officer | 卖出 | 400 | $10,655 |
| 2026-09-01 | Hansen Gwenn | Chief Scientific Officer | 买入 | 1,452 | $2,701 |
| 2026-09-01 | Hansen Gwenn | Chief Scientific Officer | 卖出 | 1,452 | $36,982 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | 买入 | 4,356 | $8,102 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | 卖出 | 1,500 | $35,803 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | 卖出 | 2,611 | $64,339 |
| 2026-08-05 | Hansen Gwenn | Chief Scientific Officer | 卖出 | 4,356 | $108,900 |
| 2026-08-04 | van Houte Hans | Chief Financial Officer | 卖出 | 2,967 | $73,129 |
| 2026-08-04 | van Houte Hans | Chief Financial Officer | 卖出 | 1,794 | $42,861 |
| 2026-08-03 | Ring Christine | Chief Legal Officer | 买入 | 5,787 | $50,463 |
| 2026-08-03 | Ring Christine | Chief Legal Officer | 卖出 | 16,589 | $382,358 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | 买入 | 3,750 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | 买入 | 3,750 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | 买入 | 3,750 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | 买入 | 2,858 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | 买入 | 2,858 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | 买入 | 2,858 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | 买入 | 3,572 | $0 |
| 2026-07-30 | Ring Christine | Chief Legal Officer | 买入 | 3,572 | $0 |
| 2026-07-30 | van Houte Hans | Chief Financial Officer | 买入 | 3,572 | $0 |
| 2026-07-30 | Hansen Gwenn | Chief Scientific Officer | 卖出 | 3,847 | $89,954 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02